ZyVersa Therapeutics (ZVSA) Earnings Date, Estimates & Call Transcripts $0.68 +0.13 (+24.24%) Closing price 05/7/2025 04:00 PM EasternExtended Trading$0.62 -0.06 (-8.73%) As of 04:21 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock ZyVersa Therapeutics Earnings Summary Upcoming Q3 Earnings DateMay. 13Before Market OpensEstimatedConsensus EPS (Aug. 9) -$5.20 Actual EPS (Aug. 9) -$3.31 Beat By $1.89 ZyVersa Therapeutics announced Q2 2024 earnings on August 9, 2024, reporting an EPS of -$3.31, which beat the consensus estimate of -$5.20 by $1.89. With a trailing EPS of $0.00, ZyVersa Therapeutics' earnings are expected to decrease next year, from ($22.70) to ($46.10) per share. Q2 2024 Earnings ResourcesQ2 2024 Earnings Report Press Release (8-K)ZVSA Upcoming EarningsZyVersa Therapeutics' next earnings date is estimated for Tuesday, May 13, 2025, based on past reporting schedules. Powered by Get ZyVersa Therapeutics Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on ZyVersa Therapeutics and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataZVSA Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter. ZyVersa Therapeutics Analyst EPS EstimatesCurrent Year EPS Consensus Estimate ($22.70) EPSNext Year EPS Consensus Estimate ($46.10) EPS ZyVersa Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 5/13/2025(Estimated)--------8/9/2024--$5.20-$3.31+$1.89-$3.31--5/15/2024Q1 2024-$3.70-$4.53 -$0.83-$4.53--11/14/2023Q3 2023-$56.00-$31.50+$24.50-$0.09--8/21/2023Q2 2023--$1,459.50 -$1,459.50-$3.50--5/12/2023Q1 2023--$136.50 -$136.50-$0.39-- ZyVersa Therapeutics Earnings - Frequently Asked Questions When is ZyVersa Therapeutics's earnings date? ZyVersa Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, May 13th, 2025 based off last year's report dates. Learn more on ZVSA's earnings history. Did ZyVersa Therapeutics beat their earnings estimates last quarter? In the previous quarter, ZyVersa Therapeutics (NASDAQ:ZVSA) reported ($3.31) earnings per share (EPS) to beat the analysts' consensus estimate of ($5.20) by $1.89. Learn more on analysts' earnings estimate vs. ZVSA's actual earnings. How much profit does ZyVersa Therapeutics generate each year? ZyVersa Therapeutics (NASDAQ:ZVSA) has a recorded net income of -$98.30 million. ZVSA has generated $0.00 earnings per share over the last four quarters. What is ZyVersa Therapeutics's EPS forecast for next year? ZyVersa Therapeutics's earnings are expected to decrease from ($22.70) per share to ($46.10) per share in the next year. More Earnings Resources from MarketBeat Related Companies Omega Therapeutics Earnings Date Cyclerion Therapeutics Earnings Date NKGen Biotech Earnings Date Lipella Pharmaceuticals Earnings Date Aytu BioPharma Earnings Date Avalon GloboCare Earnings Date AIM ImmunoTech Earnings Date Sonoma Pharmaceuticals Earnings Date China Pharma Earnings Date GT Biopharma Earnings Date Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Disney Stock Jumps on Earnings—Is the Magic Sustainable?Archer Stock Eyes Q1 Earnings After UAE UpdatesFord Motor Stock Rises After Earnings, But Momentum May Not Last Broadcom Stock Gets a Lift on Hyperscaler Earnings & CapEx BoostPalantir Stock Drops Despite Stellar Earnings: What's Next?Is Eli Lilly a Buy After Weak Earnings and CVS-Novo Partnership?Is Reddit Stock a Buy, Sell, or Hold After Earnings Release? This page (NASDAQ:ZVSA) was last updated on 5/8/2025 by MarketBeat.com Staff From Our PartnersAll Signs Point To Collapse - 401(k)s/IRAs /Are DoomedRetiring? Not so Fast..Hold Onto Your Bootstraps For A Long Road AheadAmerican Hartford Gold | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredTrump to redistribute trillions of dollars Seeing how the media and other analysts are covering Trump’s actions – it’s laughable. At least it would be la...Porter & Company | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | SponsoredNew breed of trader (Wall Street hates us?)Wall Street big wigs and old-money bankers can’t touch this 1 type of stock. And that opens the door for tr...Timothy Sykes | Sponsored270x more lucrative than NVIDIA???270x more lucrative than NVIDIA??? If you've missed out on NVIDIA's recent 1,600% run... Don't worry. ...Behind the Markets | SponsoredTrump’s Secret WeaponALERT: Trump's 2024 Trade War Starts NOW The Dow just nosedived—and it's not a coincidence. Trump's new ...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ZyVersa Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ZyVersa Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ZVSA Stock Free ZVSA Stock Alerts